Measurement and Management of QT Interval Prolongation for General Physicians

被引:26
|
作者
Indraratna, Praveen [1 ,2 ,3 ]
Tardo, Daniel [4 ,5 ]
Delves, Madeline [6 ]
Szirt, Richard [2 ]
Ng, Ben [1 ,3 ]
机构
[1] Prince Wales Hosp, Dept Cardiol, Sydney, NSW 2031, Australia
[2] St George Hosp, Dept Cardiol, Sydney, NSW, Australia
[3] Univ New South Wales, Fac Med, Sydney, NSW, Australia
[4] St Vincents Hosp, Dept Med, Sydney, NSW, Australia
[5] Univ Notre Dame, Sch Med, Sydney, NSW, Australia
[6] Bloomfield Hosp, Dept Psychiat, Orange, NSW, Australia
关键词
torsades de pointes; QT interval; electrocardiogram; antipsychotics; antiarrhythmics; TORSADES-DE-POINTES; CLINICAL-PRACTICE GUIDELINES; NEW-ZEALAND COLLEGE; LONG-QT; RISK-ASSESSMENT; ECG ANALYSIS; HEART-RATE; CLARITHROMYCIN; SCHIZOPHRENIA; LEVOFLOXACIN;
D O I
10.1007/s11606-019-05477-7
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
One of the more challenging aspects of ECG interpretation is measurement and interpretation of the QT interval. This interval represents the time taken for the ventricles to completely repolarise after activation. Abnormal prolongation of the QT interval can lead to torsades de pointes, a form of potentially life-threatening polymorphic ventricular tachycardia (VT). Detection of a prolonged QT interval is essential as this can be a reversible problem, particularly in the context of the use of a variety of commonly prescribed medications in the hospital setting. Automated ECG printouts cannot be relied upon to diagnose QT interval prolongation; thus, the onus is on the clinician to identify it. This is a difficult task, as the normal QT interval is typically measured relative to the heart rate. Therefore, the QT interval often requires "correction" for the current heart rate, in order to correctly stratify the risk of torsades de pointes. A wealth of correctional formulae have been derived, but none has proven superior. We present an approach to the ECG in this context, and a step-by-step guide to manually measuring and correcting the QT interval, and an approach to management in common hospital-based clinical scenarios.
引用
收藏
页码:865 / 873
页数:9
相关论文
共 50 条
  • [31] Psychoactive Drugs and Prolongation of the QT Interval
    Deruvo, Gaetano
    Vendramin, Andrea
    Di Sciascio, Guido
    HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS, 2009, 11 (04) : 11 - 19
  • [32] Clinical relevance and management of drug-related QT interval prolongation
    Crouch, MA
    Limon, L
    Cassano, AT
    PHARMACOTHERAPY, 2003, 23 (07): : 881 - 908
  • [33] Citalopram (Celexa) and QT Interval Prolongation
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2012, 54 (1398): : 71 - 72
  • [34] IS QT(C) INTERVAL PROLONGATION HARMFUL
    MORGANROTH, J
    RODEN, D
    LIPICKY, R
    AMERICAN JOURNAL OF CARDIOLOGY, 1993, 72 (06): : B32 - B32
  • [36] Biventricular pacing and QT interval prolongation
    Bhatia, Atul
    Nangia, Vikram
    Solis, Joaquin
    Dhala, Anwer
    Sra, Jasbir
    Akhtar, Masood
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2007, 18 (06) : 623 - 627
  • [37] Drug-induced QT interval prolongation: mechanisms and clinical management
    Nachimuthu, Senthil
    Assar, Manish D.
    Schussler, Jeffrey M.
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2012, 3 (05) : 241 - 253